Abaxis Inc Sample Contracts

ABAXIS, INC.
Registration Rights Agreement • May 13th, 2002 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
AutoNDA by SimpleDocs
ABAXIS, INC. AND
Rights Agreement • May 16th, 2003 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
3240 Whipple Road, Union City, CA 94587 Phone 510 . 675 . 6500 Fax 510 . 441 . 6150 www.abaxis.com
Abaxis Inc • August 9th, 2005 • In vitro & in vivo diagnostic substances • California
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 13th, 2002 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
ABAXIS, INC.
Securities Subscription Agreement • October 19th, 2000 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
WITNESSETH:
Stock Purchase Agreement • September 29th, 1997 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
AGREEMENT AND PLAN OF MERGER by and among ZOETIS INC., ZEUS MERGER SUB, INC. and ABAXIS, INC. dated as of May 15, 2018
Agreement and Plan of Merger • May 16th, 2018 • Abaxis Inc • Measuring & controlling devices, nec • Delaware

AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of May 15, 2018, by and among Zoetis Inc., a Delaware corporation (“Parent”), Zeus Merger Sub, Inc., a California corporation and an indirect wholly owned subsidiary of Parent (“Merger Sub”), and Abaxis, Inc., a California corporation (the “Company”).

WITNESSETH:
Stock Purchase Agreement • September 29th, 1997 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
RECITALS
Management Rights Agreement • November 25th, 1998 • Abaxis Inc • In vitro & in vivo diagnostic substances
51 3 WAIVER IS A MATERIAL INDUCEMENT FOR LANDLORD TO ENTER AND ACCEPT THIS AMENDMENT.
Abaxis Inc • June 30th, 1997 • In vitro & in vivo diagnostic substances
LICENSE AGREEMENT
License Agreement • August 10th, 2009 • Abaxis Inc • Measuring & controlling devices, nec • Massachusetts

This license agreement provides Abaxis the co-exclusive opportunity to utilize these technologies to expand the Abaxis product portfolio and enter on a large scale the professional veterinary rapid diagnostic market. This includes point of care tests for infectious diseases, hormones and therapeutic drugs. The total market for these types of tests in the animal health and laboratory animal research is estimated to be over $100,000,000 in the United States alone.

Lease Agreement Basic Lease Information
Lease Agreement • February 13th, 2001 • Abaxis Inc • In vitro & in vivo diagnostic substances • California

Adjustments to Base Rent: Commencing on January 1, 2002, the monthly Base Rent shall increase to $71,076.72; Commencing on January 1, 2003, the monthly Base Rent shall increase to $73,919.79; Commencing on January 1, 2004, the monthly Base Rent shall increase to $76,876.58; Commencing on January 1, 2005, the monthly Base Rent shall increase to $79,951.64; Commencing on January 1, 2006, the monthly Base Rent shall increase to $83,149.71; Commencing on January 1, 2007, the monthly Base Rent shall increase to $86,475.70; Commencing on January 1, 2008, the monthly Base Rent shall increase to $89,934.73; Commencing on January 1, 2009, the monthly Base Rent shall increase to $93,532.12; and Commencing on January 1, 2010, the monthly Base Rent shall increase to $97,273.40.

SECOND AMENDMENT TO THE EXCLUSIVE AGREEMENT BETWEEN ABBOTT POINT OF CARE INC. AND ABAXIS, INC.
The Exclusive Agreement • August 9th, 2017 • Abaxis Inc • Measuring & controlling devices, nec • Illinois

This Second Amendment (“Second Amendment”) to that certain Exclusive Agreement (“Agreement”) dated as of March 7, 2017, is effective as of April 19, 2017 (“Amendment Effective Date”) between Abaxis, Inc. (“ABAXIS”) and Abbott Point of Care Inc. (“ABBOTT”) relating to the appointment of ABBOTT to sell and distribute Abaxis Products. Any capitalized term used and not otherwise defined herein shall have the meaning set forth in the Agreement.

ABAXIS, INC.
Securities Subscription Agreement • January 5th, 2001 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
Fifth Amendment to Lease Agreement
Fifth Amendment to Lease Agreement • February 9th, 2016 • Abaxis Inc • Measuring & controlling devices, nec

This Fifth Amendment to Lease Agreement (this “Amendment”) is entered into as of December 17, 2015 (the "Effective Date"), by and among WHIPPLE ROAD HOLDINGS, LLC, a Delaware limited liability company, SFP CROSSROADS, LLC, a Delaware limited liability company, and WOODSTOCK BOWERS, LLC, a Delaware limited liability company (collectively, “Landlord”), and ABAXIS, INC., a California corporation (“Tenant”).

AMENDMENT TO MASTER AGREEMENT
Master Agreement • August 9th, 2013 • Abaxis Inc • Measuring & controlling devices, nec

This Amendment is entered into this 4th of April, 2013, by and among the Kansas State University Institute for Commercialization (“KSUIC”) (f/k/a the National Institute for Strategic Technology Acquisition and Commercialization), a Kansas non-profit corporation, the Kansas State University Research Foundation, a Kansas non-profit corporation (“KSURF”) and ABAXIS, Inc., a California corporation (“ABAXIS”). KSUIC, KSURF, and ABAXIS are collectively referred to as “Parties.”

AGREEMENT
Agreement • July 1st, 2002 • Abaxis Inc • In vitro & in vivo diagnostic substances
AutoNDA by SimpleDocs
CONFIDENTIAL DISTRIBUTOR AGREEMENT
Distributor Agreement • June 14th, 2012 • Abaxis Inc • Measuring & controlling devices, nec • California

This Agreement made and entered into this 1st day of April, 2010 by and between Lextron, Inc. with its principal office at 620 “O” Street, P.O. Box 1240 Greeley CO 80632 (hereinafter called “Distributor”); and ABAXIS, Inc., a California corporation with its principal office at 3240 Whipple Road, Union City, California 94587 (hereinafter called “ABAXIS”).

EXCLUSIVE AGREEMENT
Exclusive Agreement • February 11th, 2013 • Abaxis Inc • Measuring & controlling devices, nec

THIS EXCLUSIVE AGREEMENT (“Agreement”) is made and entered into on October 26, 2012 by and between Abbott Point of Care Inc., a Delaware corporation, having its principal place of business at 400 College Road East, Princeton, NJ 08540 (“Abbott”), and Abaxis, Inc., a Delaware corporation with offices at 3240 Whipple Road, Union City, CA 94587 (“Abaxis”), and effective as of January 2, 2013 (“Effective Date”). Abbott and Abaxis are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.

CONFIDENTIAL SETTLEMENT AGREEMENT
Confidential Settlement Agreement • November 9th, 2012 • Abaxis Inc • Measuring & controlling devices, nec • California

This CONFIDENTIAL SETTLEMENT AGREEMENT (the “Agreement”) is entered into effective the 24th day of September 2012 (the “Effective Date”), by and between Abaxis, Inc., a California corporation with its principal place of business at 3240 Whipple Road, Union City, California 94587 (“Abaxis”), and Cepheid, a California corporation with its principal place of business at 904 Caribbean Drive, Sunnyvale, California 94089 (“Cepheid”). Abaxis and Cepheid are hereinafter referred to respectively as a “Party” and collectively as the “Parties.”

MODIFICATION TO LOAN AND SECURITY AGREEMENT
Loan and Security Agreement • February 12th, 2003 • Abaxis Inc • In vitro & in vivo diagnostic substances

This Third Modification to Loan and Security Agreement (this "Modification") is entered into by and between Abaxis, Inc., a California corporation ("Borrower") and COMERICA BANK-CALIFORNIA, a California banking corporation ("Bank") as of this 21st day of October 2002 at San Jose, California.

ABAXIS, INC. AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT for CLINTON H. SEVERSON
Employment Agreement • February 9th, 2011 • Abaxis Inc • Measuring & controlling devices, nec • California

This Amended and Restated Executive Employment Agreement (“Agreement”) is entered into as of the 27th day of October, 2010 (the “Effective Date”), by and between Clinton H. Severson (“Executive”) and Abaxis, Inc., a California corporation (“Company”). As of the Effective Date, this Agreement amends, restates and supersedes in its entirety the Employment Agreement by and between the Executive and the Company dated July 11, 2005 (“Prior Agreement”).

Second Amendment to Lease Agreement
Second Amendment • June 14th, 2010 • Abaxis Inc • Measuring & controlling devices, nec

This Second Amendment to Lease Agreement (the “Amendment”) is made and entered into as of November 20, 2000, by and between PRINCIPAL DEVELOPMENT INVESTORS, LLC, a Delaware limited liability company (“Landlord”), and ABAXIS, INC., a California corporation (“Tenant”), with reference to the following facts.

DISTRIBUTION AGREEMENT
Distribution Agreement • May 31st, 2016 • Abaxis Inc • Measuring & controlling devices, nec • California

This DISTRIBUTION AGREEMENT (the “Agreement”) is made effective as of October 1, 2014 (the “Effective Date”) by and between Patterson Management, LP, a Minnesota Limited Partnership with an office at 137 Barnum Road, Devens MA 01434 (hereinafter called “Distributor”) and ABAXIS, Inc., a California corporation with its principal office at 3240 Whipple Road, Union City, California 94587 (“ABAXIS”).

LOAN REVISION/EXTENSION AGREEMENT
Extension Agreement • November 13th, 2002 • Abaxis Inc • In vitro & in vivo diagnostic substances

This Loan Revision Agreement refers to the loan evidenced by the above Note dated March 13, 2002 in favor of Bank executed by Abaxis, Inc. in the amount of $1,250,000.00 payable in full on September 11, 2002. Said Note is secured by a Deed of Trust dated N/A (hereinafter referred to as the "Encumbrance"), recorded on N/A as Instrument No. N/A in the Office County Recorder of N/A County California.

ENGAGEMENT AGREEMENT
Engagement Agreement • August 14th, 2000 • Abaxis Inc • In vitro & in vivo diagnostic substances • Arizona
MASTER AGREEMENT
Master Agreement • June 13th, 2011 • Abaxis Inc • Measuring & controlling devices, nec • California

This Master Agreement (this “Agreement”) is dated as of January 26, 2011 (“Effective Date”) by and among the National Institute for Strategic Technology Acquisition and Commercialization, a Kansas non-profit corporation (“NISTAC”), the Kansas State University Research Foundation, a Kansas non-profit corporation (“KSURF”) and ABAXIS, Inc., a California corporation (“ABAXIS”). NISTAC, KSURF and ABAXIS are also each referred to as a “Party” or collectively as the “Parties.”

First Amendment to Lease Agreement
To Lease Agreement • June 14th, 2010 • Abaxis Inc • Measuring & controlling devices, nec

This First Amendment to Lease Agreement (the “Amendment”) is made and entered into as of August 28, 2000, by and between Principal Development Investors, LLC, a Delaware limited liability company (“Landlord”) and Abaxis, Inc, a California corporation (“Tenant”), with reference to the following facts.

EMPLOYEE RETENTION INCENTIVE AGREEMENT
Employee Retention Incentive Agreement • August 14th, 2001 • Abaxis Inc • In vitro & in vivo diagnostic substances

THIS EMPLOYEE INCENTIVE AGREEMENT(hereinafter referred to as "Agreement") is made and entered into by and between Alberto Santa Ines (hereinafter referred to as "employee") and Abaxis, Inc. (hereinafter referred to as "Company") on April 13, 2001.

Corporate Headquarters 3240 Whipple Road, Union City, CA 94587 Phone: 510.675.6500 Fax: 510.441.6150 www.abaxis.com
Separation Agreement • August 21st, 2014 • Abaxis Inc • Measuring & controlling devices, nec • California

Abaxis, Inc. (the “Company”) recognizes and appreciates your valuable service to the Company, and wishes you the very best as you head into retirement. In order to provide the Company with a smooth transition of your responsibilities to other personnel, we are offering you the terms set forth below:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!